- Nobel Laureate Jennifer Doudna enters AI protein design arenaJennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene-editing, is dipping her toes into a new, buzzy field: AI-powered pro…Fierce Biotech · 11d ago↗ source
- Why early de-risking is redefining the path to INDLonza explains why early de-risking has become a strategic imperative for biotech teams working to reach IND with confidence.Fierce Biotech · 11d ago↗ source
- Understanding Agentic AI in Clinical DevelopmentEarlier this year, my colleague Matt Harrington suggested that clinical leaders should stop asking whether their organizations have an “AI strategy”, not because strategy doesn’t matter, but becaus…Fierce Biotech